The involvement of circadian factors, such as the PER and CRY family’s genes in cancer signaling pathways, potentially impacts lung adenocarcinoma pathogenesis, suggesting that these could serve as novel biomarkers and therapeutic targets [258]. This evidence concerns the gene PER1 and cancer.